Vagal stimulation in brain dead donor rats decreases chronic allograft nephropathy in recipients

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 544-549

  Hoeger, Simone ^a   Fontana, Johann ^a,b   Jarczyk, Jonas ^a   Selhorst, Jochen ^a   Waldherr, Rüdiger ^a   Krämer, Bernhard K ^a   Schnuelle, Peter ^a   Yard, Benito A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Brain death; Chronic allograft nephropathy; Kidney transplantation; Rat model; Vagus nerve

Indexed keywords

CREATININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN DEAD DONOR; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROSTIMULATION THERAPY; FISHER RAT; FUNCTIONAL ASSESSMENT; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; LEWIS RAT; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; RAT STRAIN; URINALYSIS; VAGUS NERVE STIMULATION; VASCULAR DISEASE; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL; BRAIN DEATH; DONOR; ELECTROSTIMULATION; FISCHER 344 RAT; GLOMERULONEPHRITIS; GRAFT REJECTION; KIDNEY; KIDNEY TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; VAGUS NERVE;

ALLOGRAFTS; ANIMALS; BRAIN DEATH; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; GLOMERULONEPHRITIS; GRAFT REJECTION; KIDNEY; KIDNEY TRANSPLANTATION; MALE; RATS, INBRED F344; RATS, INBRED LEW; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VAGUS NERVE;

EID: 84895750900     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft451     Document Type: Article

References (35)

1. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-296
2. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388
3. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M et al. Modulation of TNF release by choline requires Alpha7 subunit nicotinic acetylcholine receptor- mediated signaling. Mol Med 2008; 14: 567-574
4. Yeboah MM, Xue X, Duan B et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 2008; 74: 62-69
5. Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462
6. Bernik TR, Friedman SG, Ochani M et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231-1236
7. Su CF, Kuo TB, Kuo JS et al. Sympathetic and parasympathetic activities evaluated by heart-rate variability in head injury of various severities. Clin Neurophysiol 2005; 116: 1273-1279
8. Goldstein B, Kempski MH, DeKing D et al. Autonomic control of heart rate after brain injury in children. Crit Care Med 1996; 24: 234-240
9. Hoeger S, Yard BA. Brain death induced inflammation: possible role of the cholinergic anti-inflammatory pathway. In: Novitzky D, Cooper DKC (eds). The Brain-Dead Organ Donor. New York: Springer, 2013
10. Hoeger S, Bergstraesser C, Selhorst J et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant 2010; 10: 477-489
11. Hing A, Hicks M, Gao L et al. The case for a standardised protocol that includes hormone resuscitation for the management of the cadaveric multiorgan donor. Crit Care Resusc 2005; 7: 43-50
12. Kotsch K, Ulrich F, Reutzel-Selke A et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248: 1042-1050
13. Mascia L, Pasero D, Slutsky AS et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304: 2620-2627
14. Schnuelle P, Gottmann U, Hoeger S et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302: 1067-1075
15. Hoeger S, Gottmann U, Liu Z et al. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int 2007; 20: 790-799
16. Hoeger S, Reisenbuechler A, Gottmann U et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int 2008; 21: 1072-1080
17. Hoeger S, Petrov K, Reisenbuechler A et al. The additional detrimental effects of cold preservation on transplantation-associated injury in kidneys from living and brain-dead donor rats. Transplantation 2009; 87: 52-58
18. Solez K, Benediktsson H, Cavallo T et al. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996; 28: 441-444
19. Pratschke J,Wilhelm MJ, Laskowski I et al. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001; 12: 2474-2481
20. Pratschke J, Wilhelm MJ, Laskowski I et al. The influence of donor brain death on long-term function of renal allotransplants in rats. Transplant Proc 2001; 33: 693-694
21. van der Hoeven JA, Ploeg RJ, Postema F et al. Induction of organ dysfunction and activation of inflammatory markers in donor liver and kidney during hypotensive brain death. Transplant Proc 1999; 31: 1006-1007
22. Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 1533-1542
23. Huber TS, Kluger MJ, Harris SP et al. Plasma profiles of IL-6-like and TNF-like activities in brain-dead dogs. Am J Physiol 1991; 261: 1133-1140
24. Skrabal CA, Thompson LO, Potapov EV et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res 2005; 123: 118-125
25. Schuurs TA, Gerbens F, van der Hoeven JA et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004; 4: 1972-1981
26. Damman J, Hoeger S, Boneschansker L et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol 2011; 24: 233-237
27. Benck U, Gottmann U, Hoeger S et al. Donor desmopressin is associated with superior graft survival after kidney transplantation. Transplantation 2011; 92: 1252-1258
28. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423-429
29. Sabbatini P, Wellendorph P, Hog S et al. Design, synthesis, and in vitro pharmacology of new radiolabeled gamma-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity gamma-hydroxybutyric acid binding sites. J Med Chem 2010; 53: 6506-6510
30. Schnuelle P, Lorenz D, Mueller A et al. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999; 56: 738-746
31. Biswas AK, Scott WA, Sommerauer JF et al. Heart rate variability after acute traumatic brain injury in children. Crit Care Med 2000; 28: 3907-3912
32. Bloomfield DM, Zweibel S, Bigger JT, Jr et al. R-R variability detects increases in vagal modulation with phenylephrine infusion. Am J Physiol 1998; 274: H1761-H1766
33. Hayano J, Sakakibara Y, Yamada A et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991; 67: 199-204
34. Vathsala A. Preventing renal transplant failure. Ann Acad Med Singapore 2005; 34: 36-43
35. Keith DS, DeMattos A, Golconda M et al. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol 2005; 16: 1512-1521